Trajenta/Jentaduo (linagliptin (linagliptin/metformin))

pCPA File Number: 20873

Negotiation Status:

Concluded with an LOI

Indication(s):

Diabetes Mellitus, Type 2

Sponsor/Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

CDA-AMC Project Number:

SR0244-000

pCPA Engagement Letter Issued:

2015-09-04

Negotiation Process Concluded:

2016-04-12